FABP4 and atherosclerosis: Our results showed that oridonin inhibited atherosclerosis, as it performed double duty on lipid modulation and anti‐inflammation properties in macrophages via fatty acid binding protein 4 (FABP4)/peroxisome proliferator‐activated receptor gamma (PPARγ) pathway.